MetaStat is selling for under 6.0E-4 as of the 8th of February 2026; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 6.0E-4. MetaStat has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 10th of November 2025 and ending today, the 8th of February 2026. Click here to learn more.
MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The companys therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. The company has 5.88 M outstanding shares. More on MetaStat
MetaStat [MTST] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 205. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MetaStat's market, we take the total number of its shares issued and multiply it by MetaStat's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. MetaStat conducts business under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 5.88 M outstanding shares.
MetaStat currently holds about 316.93 K in cash with (2.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check MetaStat Probability Of BankruptcyOwnership AllocationRoughly 98.44 % of MetaStat outstanding shares are held by general public with 1.56 pct. owned by insiders and only 0.0 % by institutional investors.
Check MetaStat Ownership Details
The company recorded a loss per share of 0.61. MetaStat had not issued any dividends in recent years. The entity had 1:15 split on the 8th of October 2015. MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The companys therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MICROTEST INC operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people.The quote for MetaStat is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about MetaStat contact the company at 617-531-6500 or learn more at https://www.metastat.com.
MetaStat has some characteristics of a very speculative penny stock
MetaStat appears to be risky and price may revert if volatility continues
MetaStat has high likelihood to experience some financial distress in the next 2 years
MetaStat has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
MetaStat currently holds 1000 K in liabilities with Debt to Equity (D/E) ratio of 839.5, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. MetaStat has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist MetaStat until it has trouble settling it off, either with new capital or with free cash flow. So, MetaStat's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MetaStat sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MetaStat to invest in growth at high rates of return. When we think about MetaStat's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 23.3 K. Net Loss for the year was (3.18 M) with loss before overhead, payroll, taxes, and interest of (1.23 M).
MetaStat currently holds about 316.93 K in cash with (2.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
MetaStat Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 205. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MetaStat's market, we take the total number of its shares issued and multiply it by MetaStat's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Technical Drivers
As of the 8th of February, MetaStat secures the Standard Deviation of 16.53, mean deviation of 3.99, and Risk Adjusted Performance of 0.0974. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MetaStat, as well as the relationship between them.
The output start index for this execution was zero with a total number of output elements of sixty-one. MetaStat Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe MetaStat price patterns.
MetaStat Outstanding Bonds
MetaStat issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. MetaStat uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most MetaStat bonds can be classified according to their maturity, which is the date when MetaStat has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MetaStat intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MetaStat pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
MetaStat's time-series forecasting models are one of many MetaStat's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MetaStat's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Our tools can tell you how much better you can do entering a position in MetaStat without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Financial Widgets Now
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
When running MetaStat's price analysis, check to measure MetaStat's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetaStat is operating at the current time. Most of MetaStat's value examination focuses on studying past and present price action to predict the probability of MetaStat's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetaStat's price. Additionally, you may evaluate how the addition of MetaStat to your portfolios can decrease your overall portfolio volatility.